Theta Burst Stimulation for Motor Recovery
Launched by NATIONAL TAIWAN UNIVERSITY HOSPITAL · Nov 6, 2022
Trial Information
Current as of June 05, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a treatment called repetitive transcranial magnetic stimulation (rTMS) to help improve motor recovery in patients who have had a stroke. The researchers want to find out how different doses of a specific type of rTMS, known as intermittent Theta Burst Stimulation (iTBS), can help patients regain movement and improve the brain's ability to control muscles after a stroke.
To participate in this trial, individuals must be at least 20 years old and have experienced a stroke within the last three months that affects one side of their body. They should have some difficulty with muscle strength in their upper limb, but they should be able to sit for at least 15 minutes. However, people with certain medical conditions, like previous strokes, severe neurological diseases, or those who are pregnant, will not be eligible. Participants can expect to receive treatment using this non-invasive technology, which aims to enhance their recovery process. This study is currently looking for volunteers, and all genders are welcome to apply.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1.Unilateral ischemic or hemorrhagic stroke
- • 2.Stroke within 3 months
- • 3.Medical Research Council Scale for Muscle Strength in upper limb ≤ 3
- • 4.No previous stroke, seizure, dementia, Parkinson's disease or other degenerative neurological diseases.
- • 5.Patient could sit over 15 minutes
- • 6.Age over 20
- Exclusion Criteria:
- • 1.Previous stroke, traumatic brain injury, brain tumor
- • 2.With central nervous system disease (spinal cord injury, Parkinson's disease)
- • 3.Any contraindication to rTMS (seizure, alcoholism, metal implant, pacemaker)
- • 4.Patients unable to cooperate the treatment
- • 5.Pregnancy
- • 6.Depression
About National Taiwan University Hospital
National Taiwan University Hospital (NTUH) is a leading medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a pioneer in medical education and patient care in Taiwan, NTUH integrates cutting-edge technology with comprehensive clinical expertise to facilitate groundbreaking studies across various medical fields. The hospital’s dedicated research team collaborates with local and international partners to enhance the understanding of diseases and improve treatment outcomes. By prioritizing patient safety and ethical standards, NTUH strives to contribute to the global medical community and foster advancements in healthcare practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taipei, , Taiwan
Taipei, , Taiwan
Patients applied
Trial Officials
Meng Ting Lin, M.D.
Principal Investigator
The Department of Physical Medicine and Rehabilitation, National Taiwan University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials